510(k) K010337
K010337 is an FDA 510(k) premarket notification submitted by Quantimetrix Corp. for the device "LIPOPRINT SYSTEM, LDL SUBFRACTIONS". The FDA issued a decision of Substantially Equivalent on July 25, 2001. The device falls under product code JHO (Electrophoretic Separation, Lipoproteins), a Class I device regulated under 21 CFR 862.1475. Quantimetrix Corp. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 25, 2001
- Date Received
- February 5, 2001
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Electrophoretic Separation, Lipoproteins
- Device Class
- Class I
- Regulation Number
- 862.1475
- Review Panel
- CH
- Submission Type